Patents Examined by Jane Williams
  • Patent number: 5674714
    Abstract: A process for inducing cytochrome P-450 enzyme production in bacteria of the genus Streptomyces using inducers such as soybean flour, genistein or genistin is described. Uses for the cytochrome P-450 enzymes produced are also discussed as is a process for using genetically engineered Streptomyces to determine the mutagenicity of chemicals.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: October 7, 1997
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Daniel Anthony Kunz, Sima Fateme Sariaslani
  • Patent number: 5637475
    Abstract: There is presented a time-temperature indicator method for determining lelity of high-temperature food processing using a capsule comprising a cylindrical tube having a closed end and an open end, a cap for connection to and removal from the open end to close and open the tube, and a solution in the tube which is reactive to accumulated temperature and time exposure to fluoresce proportionally to the accumulated temperature and time exposure. There is further presented a time-temperature indicator system including the above capsule, a pipetting device for removing the solution from the capsule, and a spectrofluorometer for indicating the fluorescence of the solution, said fluorescence being directly correlatable to the time-temperature integral F.sub.0 by linear regression. There is still further presented methods for determining when food processed under high temperature conditions attains a selected low level of microbial population, the methods utilizing, respectively, the above systems.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: June 10, 1997
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: K. Ananth Narayan
  • Patent number: 5580750
    Abstract: A method is described to determine multidrug resistance in living cells by laser scanning confocal fluorescence microscopy of doxorubicin in sensitive and resistant tumor cells. The intracellular distribution of doxorubicin in K562 cells has been studied by laser scanning confocal fluorescence microscopy. A different fluorescence pattern has been observed in sensitive and resistant cells. An intense fluorescence signal is evident on the plasma membrane of K562R cells with multidrug resistance. The fluorescence imaging of the drug offers then a new method--non destructive--to discriminate between sensitive and resistant cells, with high potential in the diagnosis of resistance in tumors in vivo. The differences in the intracellular drug distribution, as seen by laser scanning confocal fluorescence microscopy, moreover offer new indications on the mode of action of the drug in the living cell.
    Type: Grant
    Filed: April 6, 1993
    Date of Patent: December 3, 1996
    Inventors: Silvia M. Doglia, Anna M. Villa, Michel Manfait
  • Patent number: 5554535
    Abstract: The white rot fungus Scytinostroma galactinum strain F361 and mutants thereof are particularly effective in selectively grading the lignin component of lignin-containing materials, particularly processed wood pulps including chemical pulps, and also particularly effective in degrading lignin degradation products such as chlorinated degraded lignin by-products as found, for example, in E-1 effluents, and also in degrading chlorine-containing aromatic compounds generally as found in aqueous waste streams containing the same.
    Type: Grant
    Filed: October 28, 1994
    Date of Patent: September 10, 1996
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Robert A. Blanchette, Theresa S. Brush, Roberta L. Farrell, Keith A. Krisa, Chittra Mishra
  • Patent number: 5541107
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: July 30, 1996
    Assignee: Advanced Tissue Sciences, Inc.
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5538890
    Abstract: A broad spectrum biological herbicide comprises a mammal-sparing bioherbicide fungal mutant, e.g., a S. sclerotiorum mutant, of limited survival time and geographical dissemination characteristics under standard agricultural conditions. The invention also relates to a method of obtaining herbicides of the invention comprising obtaining viable wild type bioherbicide fungal spores, subjecting these to UV light to reduce the number of viable fungi to less than 5% the initial number of spores, selecting mutants which differ from the wild type in at least one characteristic such as altered phenotype or morphology, and further selecting a mammal-sparing bioherbicide fungal mutant of reduced survival time and geographical dissemination characteristics under agricultural conditions when compared with the wild type. The invention also relates to a method of using the broad spectrum biological herbicide to reduce the number of weeds in an area.
    Type: Grant
    Filed: August 13, 1992
    Date of Patent: July 23, 1996
    Assignee: Research and Development Institute, Inc. at Montana State University
    Inventors: David C. Sands, Roger V. Miller, Eugene Ford, Gregory Kennett
  • Patent number: 5518892
    Abstract: An article adapted for holding a liquid sample for quantification of biological material in the liquid sample. The article includes a bag having an upper surface sheet and a lower surface sheet enclosing a volume therebetween. The bag has an upper opening through which the liquid sample can be poured into the volume in the bag. The bag also has a plurality of partitions configured to separate one or more portions of adequate sample in the bag. Also provided is a passage through which a liquid sample can be distributed throughout the volume in the bag. The bag is made of material which can be caused to form discreet non-permeable compartments for holding separate aliquots of the liquid sample.
    Type: Grant
    Filed: February 23, 1994
    Date of Patent: May 21, 1996
    Assignee: Idexx Laboratories, Inc.
    Inventors: Ali Naqui, Mark W. Pierson, Thomas R. Weschler, Steven C. Wardlaw, Michael P. Finnerty, Charles R. Carpenter
  • Patent number: 5518879
    Abstract: This invention provides a method of altering the metabolism of sphingolipids in a cell comprising contacting the cell with a fumonisin, or an analog thereof. The invention also provides a method of detecting the consumption of a fumonisin or a fumonisin analog in a subject comprising (A) detecting, in a sample from the subject, the state of the metabolic pathway of sphingolipids and (B) comparing the state of the metabolic pathway to that of a normal subject, the presence of a change in the state of the metabolic pathway indicating the consumption of a fumonisin or a fumonisin analog. Also provided is a method of detecting the presence of a fumonisin or fumonisin analog contamination in a sample from a food or feed comprising detecting a reaction of the metabolic pathway of sphingolipids, the presence of the reaction indicating the presence of a fumonisin or fumonisin analog contamination. Furthermore, novel fumonisin analogs and compositions comprising fumonisins and fumonisin analogs are provided.
    Type: Grant
    Filed: April 2, 1993
    Date of Patent: May 21, 1996
    Assignees: Emory University, The United States of America as represented by the Secretary of Agriculture
    Inventors: Alfred H. Merrill, Jr., Elaine W. Wang, Ronald T. Riley
  • Patent number: 5518915
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: May 21, 1996
    Assignee: Advanced Tissue Sciences, Inc.
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5518894
    Abstract: A rapid presence-absence method for determining if fecal coliform cells are present in a sample. Portions of the original sample are filtered and retained upon microporous filters which are placed in incubation containers having an actuating medium containing a fluorogenic substrate. The samples are incubated for predetermined durations of from about twenty minutes to six hours. After adjusting the pH is incubation to an alkaline level, the containers are irradiated and the fluorescent light emitted is measured. The measured values are adjusted for background fluorescence and corrected for extraneous sources of fluorescence. It is concluded that fecal cells are present in the original sample (i.e., at least one fecal coliform cell per 100 milliliters) when the corrected fluorescence values are positive and meet certain predetermined criteria.
    Type: Grant
    Filed: March 12, 1993
    Date of Patent: May 21, 1996
    Inventor: James D. Berg
  • Patent number: 5516680
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: May 14, 1996
    Assignee: Advanced Tissue Sciences, Inc. formerly Marrow-Tech
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5516681
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: May 14, 1996
    Assignee: Advanced Tissue Sciences, Inc.
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5516691
    Abstract: This invention relates to a module (1) for culturing and using metabolisms for maintaining microorganisms (9), particularly for cells or bacteria, comprising an outer casing (2), at least three independent membrane systems, whereof at least two are constructed as hollow fiber membranes (3) and are located in the inner space (4) of the module (1), and that the hollow fiber membranes (3) form a close packed, space network (5) and microorganisms (9) are located in the cavities of the network (5) and/or adhere to the hollow fiber membranes (3).
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: May 14, 1996
    Inventor: Jorg Gerlach
  • Patent number: 5516648
    Abstract: Reference microorganisms are sealed into an interior cavity of a microporous membrane (14, 20). In one embodiment, the reference microbes are inoculated on a element (12) which is sealed in a microporous envelope (14) (FIG. 1). In another embodiment, the reference microbes (22) are loaded into an interior bore or cavity of a microporous plastic tube or envelope (20) (FIG. 3). The microporous membrane and the reference microbes, such as spores, are immersed concurrently with items to be microbially decontaminated separately into an anti-microbial fluid. The microporous membrane is constructed of a material which is sufficiently resistant to temperature, water, strong oxidants, and other anti-microbial agents or processes used for microbial decontamination or sterilization that it retains its integrity during the immersion in any common steam, gas, or liquid microbial decontamination or sterilization fluid or system.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: May 14, 1996
    Assignee: Steris Corporation
    Inventors: Paul S. Malchesky, Donna M. Richardson
  • Patent number: 5512475
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: April 30, 1996
    Assignee: Advanced Tissue Sciences, Inc.
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5508196
    Abstract: A method for continuously preparing a sterile culture medium comprises combining separate unsterilized fluid components in separate streams into a single mainstream. The mainstream is applied to a transverse flow filtration module having a membrane which separates the mainstream into a permeate and a retentate. The permeate is fed to a bioreactor and the retentate is diverted to a centrifuge to precipitate contaminants. The clarified retentate is returned into the mainstream upstream of the transverse flow filtration module.
    Type: Grant
    Filed: July 11, 1994
    Date of Patent: April 16, 1996
    Assignee: Westfalia Separator AG
    Inventors: Klaus Mannweiler, Ralf Kuchenbecker, Werner Rosenthal
  • Patent number: 5508175
    Abstract: A fixative-stain system, which gives superior preservation of nuclear detail, is free from toxic mercury compounds, and which is simple and easy to use, includes a zinc salt and a cobalt salt, in combination, as a fixative, and at least one of Chlorazol Black E, Fast Green FCF and May-Grunwald stains, and preferably the three in admixture, as a staining composition. The fixative may also be used alone. The present fixative-stain system is suitable for fixing and staining all types of parasites such as enteric and other parasites which infect animals and humans.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: April 16, 1996
    Assignee: Allegheny-Singer Research Institute
    Inventor: Malcolm Slifkin
  • Patent number: 5506096
    Abstract: A method for controlling and/or optimising a process in which a biological system comprising mixed cultures of microorganisms, biodegradable material, one or more biogenic fluorophores and optionally other soluble and/or insoluble and/or suspended substances in an aqueous environment is subjected to one or several separation processes and/or to chemical reactions and/or to biological treatment so as to obtain as a final product purified water which has a substantially lower content of biodegradable matter than the biological system, which method comprises monitoring the microbiological activity of the biological system and/or fluctuations thereof by on-line measurement of fluorescent emission and/or variations therein for at least one of the fluorophores in the system when irradiated with light and controlling one or several parameters of the process by using results from the measurement as measured variable(s) in an on-line automatisation system.
    Type: Grant
    Filed: September 1, 1994
    Date of Patent: April 9, 1996
    Assignee: BioBalance A/S
    Inventor: Kim Helmo
  • Patent number: 5500369
    Abstract: A hand-held portable sampler uses a vacuum to induce the flow of air into an air chamber and around a deflector plate mounted substantially transverse to the overall airflow pattern and with edges thereof close to the surface of nutrient material contained in culture containers between opposite sides of the enclosure and the deflector plate to define a constricted air passage. Particulates in the air are caused to impact the surface of nutrient material contained in culture containers as air is deflected through the constricted area. The venturi effect of the constricted area causes turbulence downstream to continue the process of impacting particulates in the nutrient material downstream from the constricted area of the air deflector.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: March 19, 1996
    Assignee: NCH Corporation
    Inventor: Dale V. Kiplinger
  • Patent number: 5489532
    Abstract: An automatic test apparatus for use in a test method to determine antimicrobial drugs. The test apparatus comprises a first aluminum, electrically heatable block with holes for the insertion of test containers and a separate, second cooling aluminum block adapted to be placed periodically in contact with the heated aluminum block to cool rapidly the heated block. The test apparatus includes timed signals existing therein to alert the test user. The test apparatus is adapted to provide for the timed sequential solid heating and cooling of one or more test containers containing a test sample.
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: February 6, 1996
    Assignee: Charm Sciences, Inc.
    Inventors: Stanley E. Charm, Eliezer Zomer, Thomas Lieu, Max Gandman, Lee Gandman